Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer

Clinical trial NCT00047801 · COMPLETED

Trial details

NCT number: NCT00047801
Sponsor: Telik
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-small-cell Lung

Start date: 2002-10-01
Primary completion: 2004-09-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.